Furthermore, only four studies reported MCID thresholds, and none performed responder analyses beyond the 50% VAS reduction criterion (Shokri et al., 2021
Thank you for being a vital part of our podcast community
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications originally developed to manage type 2 diabetes mellitus and, more recently, obesity
Coverage focuses on how platforms are designed, what they manage operationally, and where clinical authority rests with licensed healthcare providers
If you're having GI side effects, if you're having fertility goals, because we don't wanna be using these medications while you're actively trying to conceive or once you are pregnant
In case there has been a definite diagnosis of acute pancreatitis, Semaglutide must be immediately discontinued